✦ LIBER ✦

Heparin dosing for percutaneous coronary angioplasty: Use of body surface area to improve initial activated clotting time values

✍ Scribed by Gene R. Pesola; David A. Pesola

Book ID: 112064721
Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 370 KB
Volume: 20
Category: Article
ISSN: 0160-9289
DOI: 10.1002/clc.4960201206

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of activated partial thrombop

Comparison of activated partial thromboplastin time to activated clotting time for adequacy of heparin anticoagulation just before percutaneous transluminal coronary angioplasty

✍ Howard P. Grill; Joel E. Spero; Jerome E. Granato 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 258 KB

Comparison of activated clotting times t

Comparison of activated clotting times to heparin management test for adequacy of heparin anticoagulation in percutaneous transluminal coronary angioplasty

✍ Helft, Gérard ;Choktron, Sylvie ;Beygui, Farzyn ;Le Feuvre, Claude ;Elalamy, Ism 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 2 views

The aim of this study was to compare the activated clotting time (ACT) obtained with the Hemochron device and the Heparin Management Test (HMT) on a new automated whole-blood coagulometer, the Thrombolytic Assessment System, in patients undergoing angioplasty. Fifty patients undergoing balloon angio